4th Annual Canadian Therapeutics Congress
The 4th Annual Canadian Therapeutics Congress was held from May 27th – 30th, 2007 at the Westin Nova Scotia, Halifax.
The theme of the 2007 congress was “the virtuous circle: Therapeutics from molecule to patient to population and back,” with sub-themes on therapeutics for vulnerable populations, therapeutic innovations; human resources in drug evaluation; health technology assessment; information technology; drug policy; and advances in therapeutics education.
We have been granted permission to post the following presentations:
Sunday May 27, 2007
Ross J Baldessarini, MD
Psychopharmacology for Suicide Prevention
David Haslam, MD, MSc, FRCPC
Righting the Wrongs of Psychopharmacology – Addressing the Physical Health of Psychiatric Patients: Focus on schizophrenia and “atypical” antipsychotics
Brendan Carr, MD, MBA
Canadian Therapeutics Congress – Satellite Symposium: Disease Management Partnerships – Creating Health Solutions
Richard Lewanczuk, MD, PhD
Chronic Disease Management: A Region-Wide, Integrated Approach
Andrew Pipe, CM, MD
Developing an Integrated System of Excellence in Cardiovascular Disease Prevention
Monday May 28, 2007
David W Nierenberg, MD
Training Students Who Are Competent in Clinical Pharmacology
Tammy J Clifford, PhD
Health Technology Assessment at CADTH: One Size Doesn’t Fit All
Brian B Hoffman, MD
Layered Approaches to Studying Drug Responses
Stanley Nattel, MD
Rational Approach to Improving Cardiac Arrhythmia Therapy
Donald Zarowny, MSc, MD
The Human Immunodeficiency Virus: Where did it come from? – Where is it going?
Peter McLeod, MD
Challenges for Pharmacology and Therapeutics Educators
Tuesday May 29, 2007
CSCP & CAPT 2007
Canadian Society of Clinical Pharmacology and Canadian Association for Population Therapeutics 2007
Sean B Rourke, PhD
Epidemiology of Vulnerable Populations: The Ontario HIV/Aids Experience
Grace Paterson, PhD
Overview of Health Informatics and Clinical Decision Support Systems
Peter J Zed, BSc, BSc (Pharm), ACPR, PharmD, FCSHP
The Role of Personal Digital Assistants in Pharmacosurveillance: A Canadian Experience Evaluating Drug-Related Hospital Visits
Susan Tett, PhD, BPharm, MPS
Using Health Informatics for Pharmacoepidemiologic Research in Australia
Noralou P Roos, PhD
Canadian Drug Policy Development Coalition and the National Pharmaceuticals Strategy
Jacques LeLorier, MD, PhD, FRCPC FISPE
Reasonable Expectations in Drug Reimbursement
Wednesday May 30, 2007
Carlo De Angelis, RPh, PharmD
Therapeutic Innovations in Oncology: Targeted Therapies Coming of Age
Jeff Kirby, MD, MA and Emily Somers, BSc Pharm
E3 Decision Making Framework – Nova Scotia CSTPC
Ross J Baldessarini, MD
Psychopharmacology: Advances & Challenges
Scott Halperin, MD
Vaccinology: From Bench to Bedside to Boardroom
Shelly McNeil, MD, FRCPC
Licensing a vaccine to prevent cancer: Clinical trials of Human papillomavirus vaccines
Mike Tierney, BSc Pharm, MSc
Public Involvement in Centralized Drug Reimbursement Processes